Sticking and picking problems are ubiquitous in tablet manufacturing. In the regulated world of drug-product manufacturing, there is often a sense of urgency to develop a new molecule. But this urgency can result in hasty decisions to enter clinical trials or submit for regulatory approval with a formulation that ultimately results in unanticipated compression scale-up problems, discusses Jonathan Gaik at Natoli Scientific.

Comments are closed.

%d bloggers like this: